Cita APA (7a ed.)
Pan, M., Lin, Y., Liu, Y., Xu, R., & Yang, J. (2024). Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer. European Journal of Clinical Pharmacology, 80(9), 1387-1398.
Cita Chicago Style (17a ed.)
Pan, Meiyu, Yan Lin, Yinhui Liu, Ruijuan Xu, y Jin Yang. "Quantitative Evaluation of the Efficacy and Safety Profiles of Two Types of Targeted Inhibitors Combined with Endocrine Therapy in ER+/HER2− metastatic Breast Cancer." European Journal of Clinical Pharmacology 80, no. 9 (2024): 1387-1398.
Cita MLA (9a ed.)
Pan, Meiyu, et al. "Quantitative Evaluation of the Efficacy and Safety Profiles of Two Types of Targeted Inhibitors Combined with Endocrine Therapy in ER+/HER2− metastatic Breast Cancer." European Journal of Clinical Pharmacology, vol. 80, no. 9, 2024, pp. 1387-1398.
Precaución: Estas citas no son 100% exactas.